Bruce Cozadd, the retiring CEO of Jazz Pharmaceuticals, has outlined a developing oncology pipeline at the company. Speaking ...

JPMorgan Chase & Co.'s Chief Executive Jamie Dimon told analysts on Wednesday he plans to stay in the job "for a few more ...

JPMorgan Chase management disabled comments on an internal webpage where the policy was announced, according to the Wall ...

AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...

The bank – the largest in the US with more than 300,000 employees worldwide – is expected to announce the change in the next ...

JPMorgan Chase on Wednesday posted record quarterly and annual earnings and revenue, reinforcing the company’s status as the ...

Big bank profits surged in the fourth quarter and Wall Street roared back to life, with net income rising 50% at JPMorgan ...

In a report released yesterday, Mike Mayo from Wells Fargo maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report). The ...

In a report released today, Glenn Schorr from Evercore ISI maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report), with a ...

Eight blockbuster drugs are expected to generate over $3bn in peak sales each according to Novartis CEO Vas Narasimhan.

JPMorgan Chase & Co. finished off 2024 with a profit that beat analyst estimates as the U.S.'s largest bank reported fourth-quarter earnings of $4.81 a share, well ahead of the FactSet consensus ...

The bank shut down a discussion on an internal website about a five-day return to office policy after dozens of employees ...